We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
How to Find a New TB Drug.
- Authors
Uehling, Mark D.
- Abstract
Reports on the discovery of the antibiotic diarylquinolines that could offer shorter treatment regimens against tuberculosis, developed by scientists at Johnson & Johnson. Use of the compound R207910; Role of 454 Corp. and the Institute for Genomic Research in the development of the treatment regimen; Statement given by Koen Andries, lead author of the research, on traditional screening and medicinal chemistry.
- Subjects
ANTIBIOTICS; TUBERCULOSIS treatment; SCIENTISTS; JOHNSON &; Johnson (Company); BIOACTIVE compounds; 454 Corp.; GENOMICS; RESEARCH institutes; ANDRIES, Koen; MEDICAL screening; PHARMACEUTICAL chemistry
- Publication
Bio-IT World, 2005, Vol 4, Issue 1, p17
- ISSN
1538-5728
- Publication type
Article